Daily News Podcast

FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome


 

The FDA approved cannabidiol oral solution for the treatment of two rare pediatric seizure disorders. Also today, it’s a good idea to urge expectant parents to have a prenatal pediatrician visit, the Trump administration proposes changes to HHS and the FDA (view the complete proposal here), and after being approved for adults, the Eversense continuous glucose monitoring system is safe, durable, and accurate in children.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Study finds widespread use of medications with depression as side effect
MDedge Dermatology
Type 2 diabetes may promote Parkinson development
MDedge Dermatology
Routine AAA screening for older men: more harm than good?
MDedge Dermatology
TNF inhibitor linked to one-third drop in total mortality
MDedge Dermatology
Inflammatory myopathy following tattoo reported in an immunocompromised patient
MDedge Dermatology
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Dermatology
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Dermatology
JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Dermatology
Patients going without as insulin prices skyrocket
MDedge Dermatology
Chilblain Lupus Erythematosus Presenting With Bilateral Hemorrhagic Bullae of Distal Halluces
MDedge Dermatology